Transcatheter Structural Heart Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Transcatheter Structural Heart Device Market covers analysis By Type (Aortic Valve Replacement, Left Atrial Appendage Occluders, Septal Defect Occluders, Mitral Valve Repair, Mitral Valve Replacement (Experimental)); Application (Congenital Heart Defects, Aortic Stenosis, Stroke, Mitral Regurgitation, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00015260
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Transcatheter Structural Heart Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET INTRODUCTION

Transcatheter aortic valve replacement (TAVR) is a new option for the treatment of aortic valve disease with minimally invasive surgery. The TAVR surgery has enhanced the possibilities for replacing the aortic valve. The transcatheter treatment has benefits over surgical intervention in recovery time, lower procedural risk, improved patient satisfaction, and avoidance of cardio-pulmonary bypass, especially in high-risk patients. The transcatheter implant is used in close the left atrial appendage (LAA), a pouch that forms part of the left atrium.

MARKET DYNAMICS

Factors driving the growth of the regulatory approvals of new and advanced structural heart devices market are, coupled with the growing prevalence of structural heart diseases. However, the high cost of cardiac surgeries is expected to hamper the growth of the market. Moreover, favorable reimbursement scenario and rising investments by major market players in transcatheter structural heart device is anticipated to boost the market growth.

MARKET SCOPE

The "Transcatheter Structural Heart Device Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of transcatheter structural heart device market with detailed market segmentation by type and application. The transcatheter structural heart device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in transcatheter structural heart device market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The transcatheter structural heart device market is segmented on the basis of type and application. Based on type, the market is segmented as aortic valve replacement, left atrial appendage occluders, septal defect occluders, mitral valve repair, and mitral valve replacement (experimental). On the basis of application, the market is categorized as congenital heart defects, aortic stenosis, stroke, mitral regurgitation, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the transcatheter structural heart device market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The transcatheter structural heart device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting transcatheter structural heart device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the transcatheter structural heart device market in these regions.

Transcatheter Structural Heart Device Market Report Analysis

Transcatheter Structural Heart Device Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Medtronic
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova plc
  • Edwards Lifesciences Corporation
  • Lepu Medical
  • Micro Interventional Devices, Inc.
  • Lifetech Scientific
  • Cryolife

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Type [Aortic Valve Replacement, Left Atrial Appendage Occluders, Septal Defect Occluders, Mitral Valve Repair, Mitral Valve Replacement
  • Experimental]
By Application
  • Congenital Heart Defects
  • Aortic Stenosis
  • Stroke
  • Mitral Regurgitation
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the transcatheter structural heart device market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from transcatheter structural heart device market are anticipated to have lucrative growth opportunities in the future with the rising demand for transcatheter structural heart device in the global market. Below mentioned is the list of few companies engaged in the transcatheter structural heart device market.

The report also includes the profiles of key players in transcatheter structural heart device market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Medtronic
  •  Boston Scientific Corporation
  •  Abbott Laboratories
  •  LivaNova plc
  •  Edwards Lifesciences Corporation
  •  Lepu Medical
  •  Micro Interventional Devices, Inc.
  •  Lifetech Scientific
  •  Cryolife
  •  Micro Interventional Devices, Inc.
  •  NeovasCryoLife, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Transcatheter Structural Heart Device Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type [Aortic Valve Replacement, Left Atrial Appendage Occluders, Septal Defect Occluders, Mitral Valve Repair, Mitral Valve Replacement
  • Experimental]
By Application
  • Congenital Heart Defects
  • Aortic Stenosis
  • Stroke
  • Mitral Regurgitation
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova plc
  • Edwards Lifesciences Corporation
  • Lepu Medical
  • Micro Interventional Devices, Inc.
  • Lifetech Scientific
  • Cryolife
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Medtronic
    2. Boston Scientific Corporation
    3. Abbott Laboratories
    4. LivaNova plc
    5. Edwards Lifesciences Corporation
    6. Lepu Medical
    7. Micro Interventional Devices, Inc.
    8. Lifetech Scientific
    9. Cryolife
    10. Micro Interventional Devices, Inc.
    11. NeovasCryoLife, Inc.

    Trends and growth analysis reports related to Medical Device : READ MORE..